The Silverstein Foundation Launches Post-Doctoral Fellowship Program to Fund Novel Research for Parkinsons’s Disease in GBA Mutation Carriers

Silverstein Foundation Announces Grant Funding to AcureX Therapeutics.

2021.08.31-Silverstein-Foundation-AcureX-Therapeutics-PRDownload

Prevail Therapeutics Acquired by Lilly

Prevail Announces First Patient Dosed

Aspen Neuroscience Announces $70 Million Series A Financing